DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
AVN-944 is an investigational drug.
There have been 6 clinical trials for AVN-944. The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2007.
The most common disease conditions in clinical trials are Atrial Fibrillation, Osteonecrosis, and Necrosis. The leading clinical trial sponsors are University of Leeds, Sheba Medical Center, and Mayo Clinic.
Recent Clinical Trials for AVN-944
|Macitentan in Pulmonary Hypertension of Sickle Cell Disease||Actelion||Phase 1|
|Macitentan in Pulmonary Hypertension of Sickle Cell Disease||Boston University||Phase 1|
|The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients.||University of Leeds||N/A|